Cargando…

An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor

SIMPLE SUMMARY: As hypoxia-inducible factor 1 (HIF-1) is recognized as a target for cancer therapy, extensive efforts have been devoted to developing its inhibitors. We provide an overview of the latest information about basic, translational, and clinical research for the development of HIF-1 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirai, Yukari, Chow, Christalle C. T., Kambe, Gouki, Suwa, Tatsuya, Kobayashi, Minoru, Takahashi, Itsuki, Harada, Hiroshi, Nam, Jin-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200185/ https://www.ncbi.nlm.nih.gov/pubmed/34200019 http://dx.doi.org/10.3390/cancers13112813

Ejemplares similares

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
por: Nagao, Ayako, et al.
Publicado: (2019)

Tumor microenvironment and radioresistance
por: Suwa, Tatsuya, et al.
Publicado: (2021)

SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Recent Advances in the Application of Cucurbitacins as Anticancer Agents
por: Zieniuk, Bartłomiej, et al.
Publicado: (2023)

Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview
por: Matiadis, Dimitris, et al.
Publicado: (2020)

Transition Metal Intercalators as Anticancer Agents—Recent Advances
por: Deo, Krishant M., et al.
Publicado: (2016)

Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
por: Sharma, Pankaj, et al.
Publicado: (2021)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
por: Zhang, Yingqian, et al.
Publicado: (2023)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
por: Edis, Zehra, et al.
Publicado: (2021)

Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes
por: Barreca, Marilia, et al.
Publicado: (2020)

HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog
por: Katagiri, Tomohiro, et al.
Publicado: (2018)

Functional and Structural Overview of G-Protein-Coupled Receptors Comprehensively Obtained from Genome Sequences
por: Suwa, Makiko, et al.
Publicado: (2011)

Overview of directly driven HIF targets
por: Basko, M M, et al.
Publicado: (1992)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021)

HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs
por: Zhao, Tao, et al.
Publicado: (2014)

UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
por: Nakashima, Ryota, et al.
Publicado: (2017)

Journey of anthraquinones as anticancer agents – a systematic review of recent literature
por: Malik, M. Shaheer, et al.
Publicado: (2021)

Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches
por: Carbone, Katya, et al.
Publicado: (2023)

Exploring developmental, functional, and evolutionary aspects of amphioxus sensory cells
por: Satoh, Gouki
Publicado: (2006)

In Search of Panacea—Review of Recent Studies Concerning Nature-Derived Anticancer Agents
por: Przystupski, Dawid, et al.
Publicado: (2019)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective
por: Kimura, Tomoki, et al.
Publicado: (2016)

Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
por: Harada, Koji, et al.
Publicado: (2017)

Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies
por: Tan, Chalet, et al.
Publicado: (2013)

An overview of the potential anticancer properties of cardamonin
por: Ramchandani, Shanaya, et al.
Publicado: (2020)

Flavonoids as Anticancer Agents
por: Kopustinskiene, Dalia M., et al.
Publicado: (2020)

Interaction of human serum albumin with anticancer agents in vitro.
por: Takahashi, I., et al.
Publicado: (1980)

Anticancer agents : frontiers in cancer chemotherapy /
Publicado: (2001)

EZH2, HIF-1, and Their Inhibitors: An Overview on Pediatric Cancers
por: Papale, Marco, et al.
Publicado: (2018)

Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents
por: Liu, Yu, et al.
Publicado: (2016)

Recent updates and future perspectives about amygdalin as a potential anticancer agent: A review
por: Shi, Jiamin, et al.
Publicado: (2019)

Spermidine as a promising anticancer agent: Recent advances and newer insights on its molecular mechanisms
por: Prasher, Parteek, et al.
Publicado: (2023)

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
por: Lee, Sang Yeul, et al.
Publicado: (2020)

Anticancer Drugs from Marine Flora: An Overview
por: Sithranga Boopathy, N., et al.
Publicado: (2010)

Overview of the Anticancer Profile of Avenanthramides from Oat
por: Turrini, Eleonora, et al.
Publicado: (2019)

Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin
por: de Luna, Francisco Canindé Ferreira, et al.
Publicado: (2023)

Radiation Recall with Anticancer Agents
por: Burris, Howard A., et al.
Publicado: (2010)

Bacteriocins as Potential Anticancer Agents
por: Kaur, Sumanpreet, et al.
Publicado: (2015)

Anticancer Agents Targeted to Sirtuins
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n7as7u2o2jkvjbsdl33plrbfuv